ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
1
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
3,474
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
nEffect of camrelizumab plus transarterial chemoembolization on massive hepatocellular carcinoma
Author(s):
S Zhang
Publication date:
2021
Journal:
Clin Res Hepatol Gastroenterol
Read this article at
ScienceOpen
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Language Documentation and Conservation
Data availability:
Comments
Comment on this article
Sign in to comment
Similar content
3,474
Immune-Related Adverse Events Mimicking Behcet's Disease in a Gastric Cancer Patient Following Camrelizumab Treatment.
Authors:
Dong Wang
,
Shasha Zhang
,
Pingan Ding
…
A case of camrelizumab-induced reactive cutaneous capillary endothelial proliferation
Authors:
L JIANG
,
Y. Yu
Efficacy and safety of transcatheter arterial chemoembolization in combination with camrelizumab and targeted agents in intermediate-stage unresectable hepatocellular carcinoma: A single-arm, prospective, real-world study
Authors:
J. Li
,
J. SHI
,
J. SONG
See all similar
Cited by
1
Transarterial chemoembolization plus a PD‐1 inhibitor with or without lenvatinib for intermediate‐stage hepatocellular carcinoma
Authors:
Yan-Jun Xiang
,
Kang Kang Wang
,
Hong-Ming Yu
…
See all cited by